Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, TTK Healthcare has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 20, 2026, to consider and approve the Scheme of Arrangement between the Company and its Equity Shareholders under Section 230 and other applicable provisions of the Companies Act, 2013 relating to the issuance of Non-Convertible Redeemable Preference Shares by way of Bonus, to the Equity Shareholders of the Company. In this connection, the company has informed that pursuant to the Company’s Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘the Code’), Trading Window for dealing in shares of the Company, for persons specified under the Code, shall remain closed from November 16, 2026 to November 22, 2026. Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company’s shares during the aforesaid period of closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.